← SynDRA
BMS-536924
SynDRA canonical compound SYN0086701 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | IGF1R |
|---|
| Mechanism of action | IGF-1 inhibitor |
|---|
All known targets
- IGF1R
- CYP3A4
- INSR
- AKT1
- CCNE1
- CDK2
- ERBB2
- KDR
- LCK
- MAPK1
- MET
- PDGFRA
Mechanisms of action (all sources)
- IGF-1 inhibitor
- CYP3A4 INHIBITOR
- IGF1R INHIBITOR
- INSR INHIBITOR
Cross-references
Synonyms
- BMS536924
- RefChem:917422
- Insulin-like Growth Factor-1 Receptor Inhibitor
- C25H26ClN5O3
- KIN001-126
- UNII-40E3AZG1MX
- N6I
- MLS006011171
- orb1300786
- SCHEMBL4132577
- SCHEMBL15974144
- SCHEMBL29157676
- SCHEMBL29402692
- SCHEMBL30540371
- SCHEMBL30753554
- BDBM27879
- CHEBI:91454
- GLXC-03510
- EX-A4566
- NSC761760
- s1012
- BMS 536924 [WHO-DD]
- AKOS024458339
- AKOS025149514
- CCG-269544
- CS-0117
- NSC-761760
- NCGC00346460-02
- NCGC00346460-04
- NCGC00346460-05
- NCGC00346460-06
- AC-32997
- AS-78828
- DA-71582
- HY-10262
- SMR004702940
- B4972
- SW218124-2
Look up BMS-536924 in the interactive SynDRA portal →